PUL-042 Inhalation Solution
PUL-042-502
Phase 2 small_molecule completed
Quick answer
PUL-042 Inhalation Solution for COVID-19 is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 2 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- COVID-19
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed